In addition, HRH2 activation in breast cancer cells was suggested to increase tumour proliferation (Cricco et al., 1994; Davio et al., 1994), whereas blocking HRH2 was reported to improve disease‐free survival in breast cancer patients (Parshad et al., 2005). Here, HRH2 is linked to neoplasm.